Amgen, Inc. (AMGN)
439.26
-8.02
(-1.79%)
USD |
NASDAQ |
Oct 23, 16:00
441.99
+2.73
(+0.62%)
After-Hours: 20:00
Amgen Price : 439.26 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 444.40 | 444.59 | 439.07 | 439.26 | 2.075M |
| Oct 22, 2026 | 441.55 | 450.98 | 437.19 | 447.28 | 3.105M |
| Oct 21, 2026 | 440.21 | 441.03 | 434.53 | 438.34 | 2.611M |
| Oct 20, 2026 | 425.58 | 439.05 | 425.11 | 438.94 | 2.217M |
| Oct 19, 2026 | 430.36 | 434.51 | 424.74 | 424.94 | 2.683M |
| Oct 16, 2026 | 437.89 | 438.82 | 431.39 | 432.49 | 2.567M |
| Oct 15, 2026 | 435.83 | 441.76 | 433.42 | 434.03 | 4.626M |
| Oct 14, 2026 | 417.83 | 428.05 | 415.20 | 426.11 | 3.085M |
| Oct 13, 2026 | 420.34 | 420.35 | 411.04 | 412.84 | 2.320M |
| Oct 12, 2026 | 416.12 | 417.76 | 413.44 | 417.57 | 1.721M |
| Oct 09, 2026 | 405.00 | 417.78 | 404.05 | 414.87 | 2.553M |
| Oct 08, 2026 | 409.97 | 411.84 | 400.06 | 407.44 | 2.378M |
| Oct 07, 2026 | 403.06 | 415.79 | 401.85 | 413.08 | 2.237M |
| Oct 06, 2026 | 403.30 | 405.00 | 396.01 | 402.60 | 2.037M |
| Oct 05, 2026 | 399.03 | 403.69 | 397.03 | 402.98 | 3.104M |
| Oct 02, 2026 | 410.16 | 410.16 | 401.96 | 403.04 | 3.510M |
| Oct 01, 2026 | 421.72 | 422.80 | 407.13 | 407.27 | 2.501M |
| Sep 30, 2026 | 424.01 | 426.59 | 420.63 | 421.51 | 3.131M |
| Sep 29, 2026 | 414.37 | 424.57 | 414.11 | 423.64 | 3.738M |
| Sep 28, 2026 | 411.52 | 419.02 | 410.96 | 418.13 | 2.918M |
| Sep 25, 2026 | 408.25 | 415.20 | 404.19 | 414.61 | 2.213M |
| Sep 24, 2026 | 406.09 | 409.99 | 403.88 | 406.04 | 2.525M |
| Sep 23, 2026 | 410.09 | 415.76 | 404.34 | 406.09 | 2.823M |
| Sep 22, 2026 | 405.25 | 413.00 | 398.52 | 410.24 | 3.721M |
| Sep 21, 2026 | 385.71 | 394.50 | 381.90 | 393.16 | 2.889M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Gilead Sciences, Inc. | 156.04 |
| Regeneron Pharmaceuticals, Inc. | 805.02 |
| AbbVie, Inc. | 285.64 |
| Biogen, Inc. | 250.69 |
| Abbott Laboratories | 103.70 |
Price Related Metrics
| PE Ratio | 27.29 |
| PS Ratio | 6.246 |
| PEG Ratio | 0.8607 |
| Price to Book Value | 20.32 |
| Price to Free Cash Flow | 23.45 |
| Earnings Yield | 3.66% |
| Market Cap | 237.46B |
| PEGY Ratio | 0.8033 |
| Operating PE Ratio | 18.75 |
| Normalized PE Ratio | 24.90 |